$CLRI
Cleartronic, Inc.

2024 Q3 Form 10-Q Financial Statement

#000109181824000093 Filed on August 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $1.005M
YoY Change 79.35%
Cost Of Revenue $319.7K
YoY Change 296.14%
Gross Profit $685.3K
YoY Change 42.88%
Gross Profit Margin 68.19%
Selling, General & Admin $602.4K
YoY Change 28.61%
% of Gross Profit 87.9%
Research & Development $2.000K
YoY Change 0.0%
% of Gross Profit 0.29%
Depreciation & Amortization $0.00
YoY Change -100.0%
% of Gross Profit 0.0%
Operating Expenses $606.7K
YoY Change 28.62%
Operating Profit $78.60K
YoY Change 890.69%
Interest Expense $6.260K
YoY Change 807.25%
% of Operating Profit 7.96%
Other Income/Expense, Net $6.255K
YoY Change 811.81%
Pretax Income $84.86K
YoY Change 884.41%
Income Tax
% Of Pretax Income
Net Earnings $84.86K
YoY Change 884.41%
Net Earnings / Revenue 8.44%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 229.2M shares 229.2M shares
Diluted Shares Outstanding 599.5M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $789.2K
YoY Change 85.04%
Cash & Equivalents $789.2K
Short-Term Investments
Other Short-Term Assets $71.52K
YoY Change -21.69%
Inventory $129.9K
Prepaid Expenses $71.52K
Receivables $406.7K
Other Receivables $4.860K
Total Short-Term Assets $1.402M
YoY Change 21.99%
LONG-TERM ASSETS
Property, Plant & Equipment $39.86K
YoY Change 122.87%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $247.2K
YoY Change 130.86%
TOTAL ASSETS
Total Short-Term Assets $1.402M
Total Long-Term Assets $247.2K
Total Assets $1.649M
YoY Change 31.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $127.2K
YoY Change 45.96%
Accrued Expenses $12.89K
YoY Change -46.09%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.580M
YoY Change 42.05%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $40.10K
YoY Change -57.92%
Total Long-Term Liabilities $40.10K
YoY Change -57.92%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.580M
Total Long-Term Liabilities $40.10K
Total Liabilities $1.620M
YoY Change 34.16%
SHAREHOLDERS EQUITY
Retained Earnings -$15.21M
YoY Change 0.13%
Common Stock $2.291K
YoY Change 0.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $29.61K
YoY Change
Total Liabilities & Shareholders Equity $1.649M
YoY Change 31.27%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $84.86K
YoY Change 884.41%
Depreciation, Depletion And Amortization $0.00
YoY Change -100.0%
Cash From Operating Activities $108.2K
YoY Change 152.3%
INVESTING ACTIVITIES
Capital Expenditures -$7.430K
YoY Change -450.47%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $7.430K
YoY Change -450.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities 108.2K
Cash From Investing Activities 7.430K
Cash From Financing Activities
Net Change In Cash 115.6K
YoY Change 183.66%
FREE CASH FLOW
Cash From Operating Activities $108.2K
Capital Expenditures -$7.430K
Free Cash Flow $115.6K
YoY Change 183.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001362516
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
CLEARTRONIC, INC.
dei Entity File Number
EntityFileNumber
000-55329
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
65-0958798
dei Entity Address Address Line1
EntityAddressAddressLine1
28050 US Hwy 19N
dei Entity Address City Or Town
EntityAddressCityOrTown
Clearwater
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Local Phone Number
LocalPhoneNumber
289-7620
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common stock Par Value $0.00001
dei Trading Symbol
TradingSymbol
CLRI
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
516955 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
545573 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Profit Loss
ProfitLoss
100533 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
229160695 shares
us-gaap Depreciation
Depreciation
3694 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
0 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
0 usd
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2024Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
usd
CY2023Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
clri Cancellationof Shares Of Common Stock
CancellationofSharesOfCommonStock
usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
usd
clri Series C Convertible Preferred Shares Exchanged For Common Stock
SeriesCConvertiblePreferredSharesExchangedForCommonStock
usd
CY2023Q2 clri Series C Convertible Preferred Shares Exchanged For Common Stock
SeriesCConvertiblePreferredSharesExchangedForCommonStock
usd
clri Rightofuse Asset Obtained In Exchange For New Operating Lease Liability
RightofuseAssetObtainedInExchangeForNewOperatingLeaseLiability
usd
CY2024Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
usd
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33761
dei City Area Code
CityAreaCode
813
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
229160695 shares
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
789191 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
406693 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
129910 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
21913 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
71523 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
68522 usd
CY2024Q2 clri Interest Receivable Related Party Current
InterestReceivableRelatedPartyCurrent
4860 usd
CY2023Q3 clri Interest Receivable Related Party Current
InterestReceivableRelatedPartyCurrent
2724 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
1402177 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
1155687 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
39855 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16526 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
142089 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
44373 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11966 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
29914 usd
CY2024Q2 clri Due From Related Party Non Current
DueFromRelatedPartyNonCurrent
53302 usd
CY2023Q3 clri Due From Related Party Non Current
DueFromRelatedPartyNonCurrent
53302 usd
CY2024Q2 us-gaap Other Assets
OtherAssets
53302 usd
CY2023Q3 us-gaap Other Assets
OtherAssets
53302 usd
CY2024Q2 us-gaap Assets
Assets
1649389 usd
CY2023Q3 us-gaap Assets
Assets
1299802 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
127217 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
85858 usd
CY2024Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1439578 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1105580 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12885 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
24580 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1579680 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1216018 usd
CY2024Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
40100 usd
CY2023Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
72100 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6507 usd
CY2024Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
40100 usd
CY2023Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
78607 usd
CY2024Q2 us-gaap Liabilities
Liabilities
1619780 usd
CY2023Q3 us-gaap Liabilities
Liabilities
1294625 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
229160695 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
229160695 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
229160695 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
229160695 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
2291 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
2291 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
15240104 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
15240104 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15212860 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15237292 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
29609 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
5177 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1649389 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1299802 usd
CY2024Q2 us-gaap Revenues
Revenues
1005050 usd
CY2023Q2 us-gaap Revenues
Revenues
560374 usd
us-gaap Revenues
Revenues
2183110 usd
us-gaap Revenues
Revenues
1577692 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
319728 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
132312 usd
us-gaap Cost Of Revenue
CostOfRevenue
592975 usd
us-gaap Cost Of Revenue
CostOfRevenue
324363 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
685322 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
428062 usd
us-gaap Gross Profit
GrossProfit
1590135 usd
us-gaap Gross Profit
GrossProfit
1253329 usd
CY2024Q2 us-gaap Selling Expense
SellingExpense
79913 usd
CY2023Q2 us-gaap Selling Expense
SellingExpense
62873 usd
us-gaap Selling Expense
SellingExpense
218062 usd
us-gaap Selling Expense
SellingExpense
154521 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
522515 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
353923 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1387909 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
970679 usd
CY2024Q2 us-gaap Depreciation
Depreciation
2293 usd
CY2023Q2 us-gaap Depreciation
Depreciation
1332 usd
us-gaap Depreciation
Depreciation
5140 usd
us-gaap Depreciation
Depreciation
3694 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18603 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25815 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
606721 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
420128 usd
us-gaap Operating Expenses
OperatingExpenses
1629714 usd
us-gaap Operating Expenses
OperatingExpenses
1154709 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
44052 usd
CY2024Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
6255 usd
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
686 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
19959 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1913 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6255 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
686 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
64011 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1913 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
84856 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8620 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
24432 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
100533 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
84856 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
8620 usd
us-gaap Profit Loss
ProfitLoss
24432 usd
us-gaap Profit Loss
ProfitLoss
100533 usd
CY2024Q2 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
10231 usd
CY2023Q2 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
10231 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
30805 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
30694 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
74625 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1611 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6373 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
69839 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
229160695 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228826849 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
229160695 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228745310 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599482330 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599428484 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599482330 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599346945 shares
us-gaap Net Income Loss
NetIncomeLoss
24432 usd
us-gaap Net Income Loss
NetIncomeLoss
100533 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5140 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3694 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
17948 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
11966 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
44052 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
9000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-129880 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
71083 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
107997 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-668 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5137 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
39745 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
85411 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
11942 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
301998 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-42137 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-18202 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-11072 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
398421 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-35234 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6435 usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
126185 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-126185 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6435 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
272236 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-41669 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
516955 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
68167 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
89191 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
426498 usd
us-gaap Interest Paid Net
InterestPaidNet
117 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
400 usd
clri Cancellationof Shares Of Common Stock
CancellationofSharesOfCommonStock
8 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
47863 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
5177 usd
us-gaap Profit Loss
ProfitLoss
24432 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
29609 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-55247 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
84856 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
29609 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-51379 usd
us-gaap Profit Loss
ProfitLoss
100533 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
49154 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
40534 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
8620 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
49154 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_847_eus-gaap--UseOfEstimates_zvUAtWvNGdKf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86F_zeLXfa60vSj8">USE OF ESTIMATES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In preparing the consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the balance sheet and operations for the reporting period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Although these estimates are based on management’s knowledge of current events and actions it may undertake in the future, they may ultimately differ from actual results.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Significant estimates include the assumptions used in valuation of deferred tax assets, estimated useful life of property and equipment, valuation of inventory and allowance for credit losses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
72665 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
63665 usd
CY2024Q2 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
51000 usd
CY2023Q3 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
38250 usd
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
71523 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
68522 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_zfXhr1M2zEj3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86C_ztBiD58lryS7">CONCENTRATION OF CREDIT RISK</span> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company currently maintains cash balances at one FDIC-insured banking institution. Deposits held in non interest-bearing transaction accounts are insured up to a maximum of $<span id="xdx_902_eus-gaap--CashFDICInsuredAmount_c20240630_pp0p0" title="Fdic insured amount">250,000</span> at all FDIC-insured institutions. As of June 30, 2024 and September 30, 2023, the Company had $<span id="xdx_901_ecustom--AmountOfFdicInsuranceLimit_c20240630_pp0p0" title="Amount of fdic insurance limits">129,161</span> and $<span id="xdx_907_ecustom--AmountOfFdicInsuranceLimit_c20230930_pp0p0" title="Amount of fdic insurance limits">118,140</span>, respectively, in excess of FDIC insured limits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2024Q2 clri Amount Of Fdic Insurance Limit
AmountOfFdicInsuranceLimit
129161 usd
CY2023Q3 clri Amount Of Fdic Insurance Limit
AmountOfFdicInsuranceLimit
118140 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18603 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25815 usd
CY2024Q2 us-gaap Deferred Revenue
DeferredRevenue
1479678 usd
CY2023Q3 us-gaap Deferred Revenue
DeferredRevenue
1177680 usd
CY2024Q2 us-gaap Regulated Operating Revenue
RegulatedOperatingRevenue
1005050 usd
CY2023Q2 us-gaap Regulated Operating Revenue
RegulatedOperatingRevenue
560374 usd
us-gaap Regulated Operating Revenue
RegulatedOperatingRevenue
2183110 usd
us-gaap Regulated Operating Revenue
RegulatedOperatingRevenue
1577692 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1177680 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1125511 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
2183110 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
2184124 usd
us-gaap Contract With Customer Asset Allowance For Credit Loss Writeoff
ContractWithCustomerAssetAllowanceForCreditLossWriteoff
1881112 usd
CY2023 us-gaap Contract With Customer Asset Allowance For Credit Loss Writeoff
ContractWithCustomerAssetAllowanceForCreditLossWriteoff
2131955 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1479678 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1177680 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0 shares
CY2024Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2023Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
74625 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1611 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
229160695 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228826849 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6373 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
69839 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
229160695 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228745310 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
74625 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1611 usd
CY2024Q2 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
10231 usd
CY2023Q2 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
10231 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
84856 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
8620 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
229160695 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228826849 shares
CY2024Q2 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
370321635 shares
CY2023Q2 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
370601635 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599482330 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599428484 shares
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6373 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
69839 usd
us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
30805 usd
us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
30694 usd
us-gaap Profit Loss
ProfitLoss
24432 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228745310 shares
us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
370321635 shares
us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
370601635 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599482330 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599346945 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2024Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
129910 usd
CY2023Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
21913 usd
CY2024Q2 us-gaap Advertising Expense
AdvertisingExpense
94974 usd
CY2023Q2 us-gaap Advertising Expense
AdvertisingExpense
46693 usd
us-gaap Advertising Expense
AdvertisingExpense
157266 usd
us-gaap Advertising Expense
AdvertisingExpense
77460 usd
CY2023Q1 us-gaap Area Of Land
AreaOfLand
1145 sqft
us-gaap Payments For Rent
PaymentsForRent
2134 usd
us-gaap Increase Decrease In Prepaid Rent
IncreaseDecreaseInPrepaidRent
2198 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11966 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
29914 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
12885 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
31087 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y3M
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08 pure
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08 pure
clri Amorization On Rightofuse Opeating Lease Asset
AmorizationOnRightofuseOpeatingLeaseAsset
17949 usd
CY2023 clri Amorization On Rightofuse Opeating Lease Asset
AmorizationOnRightofuseOpeatingLeaseAsset
17949 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
1389 usd
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
2429 usd
us-gaap Lease Cost
LeaseCost
19338 usd
CY2023 us-gaap Lease Cost
LeaseCost
20378 usd
us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
19590 usd
CY2023 us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
19206 usd
CY2023 clri Rightofuse Asset Obtained In Exchange For New Operating Lease Liability
RightofuseAssetObtainedInExchangeForNewOperatingLeaseLiability
47863 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6594 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
6594 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
13188 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
303 usd
CY2024Q2 clri Present Value Of Operating Lease Liability
PresentValueOfOperatingLeaseLiability
12885 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12885 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
56509 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
28040 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
16654 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11514 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
39855 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16526 usd
CY2024Q2 us-gaap Depreciation
Depreciation
2293 usd
CY2023Q2 us-gaap Depreciation
Depreciation
1332 usd
us-gaap Depreciation
Depreciation
5140 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
142089 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
44373 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
142089 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
44373 usd
CY2024Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
0 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
0 usd
CY2024Q2 us-gaap Cumulative Dividends
CumulativeDividends
236463 usd
CY2023Q3 us-gaap Cumulative Dividends
CumulativeDividends
205658 usd
CY2024Q2 clri Rent Expense
RentExpense
0 usd
CY2023Q2 clri Rent Expense
RentExpense
0 usd
clri Rent Expense
RentExpense
0 usd
clri Rent Expense
RentExpense
2343 usd
CY2024Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
9000 usd
CY2023Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
9000 usd
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
30000 usd
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
27000 usd
CY2024Q2 clri Advanced Amounts
AdvancedAmounts
53302 usd
CY2023Q4 clri Area Of Leased Facility
AreaOfLeasedFacility
1145 sqft
CY2023Q4 clri Monthly Rental Cost
MonthlyRentalCost
2134 usd
CY2023Q4 clri Monthly Rent
MonthlyRent
2198 usd
CY2021Q4 clri Area Of Leased Facility
AreaOfLeasedFacility
2000 sqft
CY2021Q4 clri Monthly Rental Cost
MonthlyRentalCost
2200 usd
CY2021Q4 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2023-11-30
us-gaap Royalty Expense
RoyaltyExpense
12010 usd
us-gaap Royalty Expense
RoyaltyExpense
7640 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
44052 usd

Files In Submission

Name View Source Status
0001091818-24-000093-index-headers.html Edgar Link pending
0001091818-24-000093-index.html Edgar Link pending
0001091818-24-000093.txt Edgar Link pending
0001091818-24-000093-xbrl.zip Edgar Link pending
clri-20240630.xsd Edgar Link pending
clri6302410q.htm Edgar Link pending
ex311.htm Edgar Link pending
ex312.htm Edgar Link pending
ex321.htm Edgar Link pending
ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
clri-20240630_cal.xml Edgar Link unprocessable
clri-20240630_def.xml Edgar Link unprocessable
clri-20240630_lab.xml Edgar Link unprocessable
clri-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
clri6302410q_htm.xml Edgar Link completed